Abstract
Corticosteroids have provided an effective means of controlling many ocular inflammatory conditions for over 30 years. Although information concerning the use of these drugs continues to expand rapidly, the pharmacologic action of steroids in ocular tissues has not been clearly defined. Interpretations of clinical and experimental studies with steroids are often limited by our lack of knowledge concerning the basic pharmacology of these hormones in the eye. In order to develop improved therapeutic approaches, it is essential the devise quantitative studies of drug efficacy (and side effects) relevant to specific ocular conditions. Recent advances in endocrinology and immunology provide some useful insights which may help to explain the observed steroid effects and provide new methods to employ these agents in the treatment of ophthalmic disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Addison T (1855) On the constitutional and local effects of disease of the suprarenal capsules. Highley, London
Allansmith MR, Lee JR, McClellan BH, Dohlman CH (1975) Evaluation of a sustained release hydrocortisone ocular insert in humans. Trans Am Acad Ophthalmol Otolaryn 79:OP128–OP136
Allison F, Smith MR, Wood WB (1955) Studies on the pathogenesis of acute inflammation. I. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J Exp Med 102:655–668
Alvarado J, Polansky JR (1979) Biological activity of cultured human trabecular cells. Invest Ophthalmol Vis Sci [ARVO Suppl] 18:241
Alvarado J, Wood I, Polansky JR (1982) Human trabecular cells II Ultrastructural characteristics of cultured trabecular cells. Invest Ophthalmol Vis Sci 23:464–478
Amatruda TT, Hurst MM, D’Esopo DN (1965) Certain endocrine and metabolic facets of the steroid withdrawal syndrome. J Clin Endocrinol Metabol 25:1207–1217
Apt L, Henrick A, Silverman LM (1979) Patient compliance with use of topical ophthalmic corticosteroid suspensions. Am J Ophthalmol 87:210–214
Armaly MF (1963 a) Effect of corticosteroids on intraocular pressure and fluid dynamics. 1. The effect of dexamethasone in the normal eye. Arch Ophthalmol 70:98–105
Armaly MF (1963 b) Effect of corticosteroids on intraocular pressure and fluid dynamics. 2. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol 70:492–499
Armaly MF (1964) Effect of corticosteroids on intraocular pressure and fluid dynamics. Arch Ophthalmol 71:636–644
Armaly MF (1965) Statistical attributes of the steroid hypertensive response in the clinically normal eye. Invest Ophthalmol 4:187–197
Armaly MF (1967) Steroids and glaucoma. In: Sampson CLM, Bahn GC, Schoei RE, Allen JH (eds) Symposium on glaucoma. Mosby, St. Louis, p 74
Aronson SB, Elliott JH (1972) Ocular inflammation. Mosby, St. Louis
Aronson SB, Moore TE (1969) Corticosteroid therapy in central stromal keratitis. Am J Ophthalmol 67:8733–896
Aronson SB, Moore TE, Williams FC, Goodner EK (1970) Corticosteroids in infectious ocular disease. In: Kaufman HE (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, p 15
Ashton N, Cook C (1951) Effect of cortisone on healing of corneal wounds. Br J Ophthalmol 35:708–717
Ashton N, Cook C (1952) In vivo observations of the effects of cortisone upon the blood vessels in rabbit ear chambers. Br J Exper Path 33:445–450
Austin P, Brown SI (1981) Inflammatory Terrien’s disease. Am J Ophthalmol 92:189–192
Ballard PL (1979) Delivery and transport of glucocorticoids to target cells. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 25
Ballard PL, Carter JP, Graham BS, Baxter JD (1975) A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinal Metab 41:290–304
Balow JE, Hurley DL, Fauci AS (1975) Immunosuppressive effects of glucocorticoids: differential effects of acute versus chronic administration on cell mediated immunity. J Immunol 114:1072–1076
Bárány EH, Scotchbrook S (1954) Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand 30:240–248
Baxter JD, Funder JW (1979) Hormone receptors. N Engl J Med 301:1149–1161
Baxter JD, Harris AW (1975) Mechanism of glucocorticoid action: general features, with reference to steroid-mediated immunosuppression. Transplant Proc 7:55–62
Baxter JD, Rousseau GG (1979) Glucocorticoid hormone action: an overview. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 1
Baxter JD, Tyrrell JB (1981) The adrenal cortex. In: Felig P, Baxter JD, Bioadus AE, Frohman LA (eds) Endocrinology and metabolism. McGraw-Hill, New York, p 385
Bayer JM, Neuner HP (1967) Cushing Syndrom und erhöhter Augeninnendruck. Deutsch Med Wochenschr 92:1791–1799
Beard C (1981) Ptosis. Mosby, St. Louis, p 61
Becker B (1965) Intraocular pressure response to topical corticosteroids. Invest Ophthalmol 4:198–205
Becker B, Cotlier E (1965) Topical corticosteroids and galactose cataracts. Invest Ophthalmol 4:806–814
Becker B, Hahn KA (1964) Topical corticosteroids and heredity in primary open-angle glaucoma. Am J Ophthalmol 57:543–551
Becker B, Mills DW (1963 a) Corticosteroids and intraocular pressure. Arch Ophthalmol 70:500–507
Becker B, Mills DW (1963 b) Elevated intraocular pressure following corticosteroid eyedrops. JAMA 185:170–172
Becker B, Podos SM, Asseff CF, Cooper DG (1973) Plasma Cortisol suppression in glaucoma. Am J Ophthalmol 75:73–76
Ben Ezra D, Ticho U, Sachs U (1976) Lymphocyte sensitivity to glucocorticoids. Am J Ophthalmol 82:866–870
Bernstein HN, Schwartz B (1962) Effects of long-term systemic steroids on ocular pressure and tonographic values. Arch Ophthalmol 68:742–753
Bernstein HN, Mills DW, Becker B (1963) Steroid-induced elevation of intraocular pressure. Arch Ophthalmol 70:15–18
Bigger JF, Palmberg PF, Becker B (1972) Increased cellular sensitivity to glucocorticoids in primary open-angle glaucoma. Invest Ophthalmol 11:832–837
Bigger JF, Palmberg PF, Zink HA (1975) In vitro corticosteroid response. Correlation with primary open-angle glaucoma and ocular corticosteroid sensitivity. Am J Ophthalmol 79:92–97
Bill A (1975) the drainage of aqueous humor. Invest Ophthalmol 14:1–3
Bird AC (1977) Is there a place for corticosteroids in the treatment of optic neuritis? In: Brockhurst RJ, Boruchoff SA, Hutchinson B, Lessell S (eds) Controversies in ophthalmology. Saunders, Philadelphia, pp 822–829
Black RL, Oglesby RB, von Sallmann L, Bunim JJ (1960) Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 174:150–171
Bloom E, Matulich DT, Lan N, Higgins SJ, Simons SS, Baxter JD (1980) Nuclear binding of glucocorticoid receptors: relations between cytosol binding, activation and the biological response. J Steroid Biochem 12:175–184
Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM (1974) Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions. Science 184:19–28
Boyd TAS, Hassard DTR, Patrick A, McLeod LE (1962) The relation of diurnal variation of plasma corticoid levels and intraocular pressure in glaucoma. Trans Can Ophthalmol Soc 24:119–134
Briggs MH, Brotherton J (1970) Steroid biochemistry and pharmacology. In: Briggs MH, Brotherton J (eds) Steroid biochemistry and pharmacology. Academic, London, p 176
Brown SI, Weller CA, Vidrich AM (1970) Effect of corticosteroid on corneal collagenase of rabbits. Am J Ophthalmol 70:744–747
Brown-Sequard CE (1856) Recherches expérimentales sur la physiologie et la pathologie des capsules surrénales. Compt Rend 43:422–425
Burde RM, Becker B (1970) Corticosteroid induced glaucoma and cataracts in contact lens wearers. JAMA 213:2075–2077
Byers B (1979) Blindness secondary to steroid injection into the nasal turbinates. Arch Ophthalmol 97:79–80 Bynny RL (1976) Withdrawal from glucocorticoid therapy. N Engl J Med 295:30–32
Cantrill HL, Palmberg PF, Zink HA, Waltman SR, Podos SM, Becker B (1975) Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure. Am J Ophthalmol 79:1012–1017
Caprioli J, Sears M (1983) Forskolin lowers intraocular pressure in rabbits, monkeys and man. Lancet 1:958–960
Carnuccio R, DiRosa M, Persico P (1980) Hydrocortisone-induced inhibition of prostaglandin biosynthesis in rat leukocytes. Br J Pharmacol 68:14–16
Chader GJ, Meltzer R, Silver J (1972) A soluble receptor for corticoids in the neural retina of the chick embryo. Biochem Biophys Res Comm 46:2026–2033
Chandler PA, Grant WM (1979 a) Corticosteroid glaucoma. In: Chandler PA, Grant WM (eds) Glaucoma. Lea and Febriger, Philadelphia, p 276
Chandler PA, Grant WM (1979 b) Filtering operations. In: Chandler PA, Grant WM (eds) Glaucoma. Lea and Febriger, Philadelphia, p 287
Claman HN (1975) How corticosteroids work. J Allergy Clin Immunol 55:145–151
Cline MJ, Melmon KL (1966) Plasma kinins and cortisone: a possible explanation of the anti-inflammatory actin of Cortisol. Science 153:1135–1138
Coles RS (1966) Steroid therapy in uveitis. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 869
Conn HO, Blitzer B (1976) Nonassociation of adrenocorticosteroid therapy and the peptic ulcer. N Eng J Med 294:473–479
Cope CL (1972) Metabolic breakdown. In: Cope CL (ed) Adrenal steroids and disease, 2nd edn. Lippincott, Philadelphia, p 80
Cope CL (1977) Adrenal steroids and disease. Pitman Medical, London
Corboy JM (1976) Corticosteroid therapy for the reduction of postoperative inflammation after cataract extraction. Am J Ophthalmol 82:923–927
Coster DJ (1980) Herpes simplex. In: Fraunfelder FT, Roy FH (eds) Current ocular therapy. Saunders, Philadelphia, p 60
Cox WV, Kupferman A, Leibowitz HH (1972) Topically applied steroids in corneal disease. Arch Ophthalmol 88::308–313
Crabtree GR, Gillis S, Smith KA (1979) Glucocorticoids and immune responses. Arthritis Rheum 22:1246–1256
Crews AJ (1963) Posterior subcapsular lens opacities in patients on long-term corticosteroid therapy. Br J Med 5346:1644–1647
Dale DC, Fauci AS, Wolff SM (1974) Alternate day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl Med 291:1154–1158
Davies P, Bonney RJ (1981) Some basic mechanisms in inflammatory responses. In: Suran A, Gery I, Nussenblatt RB (eds) Immunology of the eye: workshop III. Information Retrieval Inc, Washington DC, p 273
Davies P, Bonney R, Humes J, Kuehl F (1981) The mechanism of action of antiinflammatory drugs at the cellular level. In: Suran A, Gery I, Nussenblatt RB (eds) Immunology of the eye: workshop III. Information Retrieval Inc, Washington DC, p 411
DeFremery P, Laquer E, Reichstein Q, Spanhoff RW, Uyldert IE (1937) Corticosterone, a crystallized compound with the biological activity of the adrenal corticol hormone. Nature 139:26
Diamond JG, Kaplan HJ (1978) Lensectomy and vitrectomy for complicated cataract secondary to uveitis. Arch Ophthalmol 96:1798–1804
Dixon RB, Christy NP (1965) On the various forms of corticosteroid withdrawal syndrome. Am J Med 68:224–230
Dluhy RG, Newmark SR, Lauler DP, Thorn GW (1975) Pharmacology and chemistry of adrenal glucocorticoids. In: Azarnoff D (ed) Steroid therapy. Saunders, Philadelphia, p 1
Dohlman CH (1966) Corticosteroids in corneal surgery. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 845
Dohlman CH, Pavan-Langston D, Rose J (1972) A new ocular insert device for continuous constant-rate delivery to the eye. Ann Ophthalmol 4:823–832
Donshik PC, Berman MB, Dohlman CH, Gage J, Rose J (1978) Effect of topical corticosteroids on ulceration in alkali-burned corneas. Arch Ophthalmol 96:2117–2120
Donshik PC, Cavanaugh HD, Boruchoff SA, Dohlman CH (1981) Posterior subcapsular cataracts induced by topical corticosteroids following keratoplasty for keratoconus. Ann Ophthalmol 13:29–32
Dougherty TF, White A (1944) Influence of hormones on lymphoid tissue structure and function. The role of the pituitary adrenotrophic hormone in the regulation of the lymphocytes and other cellular elements of the blood. Endocrinology 35:1–14
Dunne JA, Travers JP (1979) Double-blind clinical trial of topical steroids in anterior uveitis. Br J Ophthalmol 63:762–767
Ebert RH, Barclay WR (1952) Changes in connective tissue reaction induced by cortisone. Ann Intern Med 37:506–518
Ellis PP (1978) Occlusion of the central retinal artery after retrobulbar corticosteroid injection. Am J Ophthalmol 85:352–356
Epstein WV (1977) A rheumatologist’s perspective on the use of immunosuppressants. In: Brockhurst RJ, Boruchoff SA, Hutchenson B, Lessell S (eds) Controversies in ophthalmology. Saunders, Philadelphia, p 758
Fahey JV, Guyre PM, Munck A (1981) Mechanisms of antiinflammatory actions of glucocorticoids. Adv Inflamm Res 2:21–51
Fairbairn WD, Thorson JC (1971) Fluorometholone, Arch Ophthalmol 86:138–141
Fauci AS (1978) Alternate-day corticosteroid therapy. Am J Med 64:729–731
Fauci AS (1979) Immunosuppressive and anti-inflammatory effects of glucocorticoids. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 449
Floman N, Zor U (1977) Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Invest Ophthalmol 16:69–73
Florini JR, Buyske DA (1959) A comparison of the rate of metabolism and biological activity of 16 OH-hydrocortisone derivatives. Arch Biochem 79:8–12
Florini JR, Smith LL, Buyske DA (1961) Metabolic fate of a synthetic corticosteroid (triamcinolone) in the dog. J Biol Chem 236:1038–1042
Flower R (1981) Glucocorticoids, phospholipase A2 and inflammation trends. Pharmacol Sci 2:186–189
Flower RJ, Blackwell GJ (1979) Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456–459
Foon KA, Yuen K, Ballintine EJ, Rosensteich DL (1977) Analysis of the systemic corticosteroid sensitivity of patients with primary open angle glaucoma. Am J Ophthalmol 83:167–173
Forman AR, Loreto JA, Tina LV (1977) Reversibility of corticosteroid-associated cataracts in children with the nephrotic syndrome. Am J Ophthalmol 84:75–78
Forsham PH, Thorn GW, Runty FTG, Hills AG (1948) Clinical studies with pituitary adrenocorticotropin. J Clin Endocrinol 8:15–66
Francois J (1954) Cortisone et tension oculaire. Am Oculistique 187:805–816
Francois J, Victoria-Troncoso V (1977) Corticosteroid glaucoma. Ophthalmologia (Basel) 174:195–209
Francois J, Heintz-Debree C, Tripathi RC (1966) The cortisone test and the heredity of primary open-angle glaucoma. Am J Ophthalmol 62:844–852
Fried J, Sabo EF (1954) 9α-Fluoro derivatives cortisone and hydrocortisone. J Am Chem Soc 76:1455–1456
Friedlaender MH (1979) Allergy and immunology of the eye. Harper and Row, New York, p 1
Friedlaender MH (1981) Models of ocular inflammation. In: Suran A, Gery I, Nussenblatt RB (eds) Immunology of the eye: workshop III. Information Retrieval Inc, Washington DC, p 231
Friedlaender MH (to be published) Steroid therapy. Int Ophthalmol Clin
Galili N, Galili J, Klein E, Rosenthal L, Nordenskjold B (1980) Human T lymphocytes become glucocorticoid-sensitive upon immune activation, Cell. Immun. 50:440–444
Gallegos AJ, Delgado-Partida P, Garzon P (1976) The presence of 6-steroid hydroxylase in human cornea. J Steroid Biochem 7:135–137
Ganley JP (1980) Uveitis. In: Fraunfelder FT, Roy FH (eds) Current ocular therapy. Saunders, Philadelphia, p 485
Garzon P, Delgado-Partida P, Gallegos AJ (1976) Progesterone metabolism by human cornea. J Steroid Biochem 7:377–379
Gaunt R (1975) History of the adrenal cortex. In: Greep RO, Astwood EB (eds) Handbook of physiology vol 7, endocrinology. American Physiological Society, Washington DC, p 12
Giles CL, Mason GL, Duff IF, McLean JA (1962) The association of cataract formation and systemic corticosteroid therapy. JAMA 182:719–722
Glenn EM, Stafford RO, Lyster SC, Bowmann BJ (1957) Relation between biological activity of hydrocortisone analogues and their rates of inactivation by rat liver enzyme systems. Endocrinology 61:128–142
Godel V, Feiler-Ofry V, Stein R (1972 a) Systemic steroids and ocular fluid dynamics. I. Analysis of the sample as a whole. Influence of dosage and duration of therapy. Acta Ophthalmol 50:655–662
Godel V, Feiler-Ofry V, Stein R (1972 b) Systemic steroids and ocular fluid dynamics. II. Systemic versus topical steroids. Acta Ophthalmol 50:664–676
Godfrey WA, Epstein WV, O’Connor GR, Kimura SJ, Hogan MJ, Nozik RA (1974) The use of chlorambucil in intractable idiopathic uveitis. Am J Ophthalmol 78:415–429
Goldmann H (1962) Cortisone glaucoma. Arch Ophthalmol 68:621–626
Gordon DM (1956) Prednisone and prednisolone in ocular disease. Am J Ophthalmol 41:593–600
Gordon DM (1959) Dexamethasone in ophthalmology. Am J Ophthalmol 48:656–660
Gordon DM, McLean JM (1950) Effects of pituitary adrenocorticotropic hormone (ACTH) therapy in ophthalmologic conditions. JAMA 142:1271–1276
Gould ES, Bird AC, Leaver PK, McDonald WI (1977) Treatment of optic neuritis by retrobulbar injection of triamcinolone. Br Med J 6075:1495–1497
Graham RO, Peyman GA (1974) Intravitreal injection of dexamethasone. Arch Ophthalmol 92:149–154
Granner DK (1979) The role of glucocorticoid hormones as biological amplifiers. In: Baxter JD, Rouseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 593
Green H, Kroman HS, Leopold IH (1955 a) Corticosteroids in the aqueous humor of the rabbit. Arch Ophthalmol 54:853–857
Green H, Sawyer IL, Leopold IH (1955 b) Investigation of corticosteriods in the aqueous humor of normal rabbit eyes. Am J Ophthalmol 30:871–873
Gregory D, Sears M, Bausher L, Mishima H, Mead A (1981) Intraocular pressure and aqueous flow are decreased by cholera toxin. Invest Ophthalmol Vis Sci 20:371–381
Haas JS, Nooten RH (1974) Glaucoma secondary to benign adrenal adenoma. Am J Ophthalmol 78:497–500
Harris AW, Baxter JD (1979) Variations in cellular sensitivity to glucocorticoids: observations and mechanisms. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 423
Harris MA, Schwartz B (1983) Dexamethasone-induced stimulation of beta-adrenergic sensitive adenylate cyclase in ciliary process epithelium. ARVO Abstracts, Suppl 24:5
Harter JG (1974) Alternate day therapy. In: Thorn GW (ed) Steroid therapy. Medcom, Kalamazoo, p 42
Harter JG, Reddy WJ, Thorn GW (1963) Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 269:591–596
Harter JG, Borgmann AR, Leaders FE (1970) Steroid potency and the determination of potency, effectiveness and toxicity of anti-inflammatory drugs for use in the eye. In: Kaufmann HE (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, p 234
Hartman FA, Brownell KA (1930) The hormone of the adrenal cortex. Science 72:76
Havener WH (1976) Corticosteroid misuse. In: Leopold IH, Burns RP (eds) Symposium on ocular therapy. Wiley, New York, p 25
Hench PS, Kendall EC, Slocumb CH, Polley HF (1949) The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis. Proc Staff Meetings Mayo Clinic 24:181–197
Hench PS, Kendall EC, Slocumb CH, Polley HF (1950) Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Intern Med 85:845–560
Hernandez MR, Wenk EJ, Weinstein BI, Ritch R, Dunn MW, Southren AL (1981) Glucocorticoid target cells in human trabeculectomy specimens. Invest Ophthalmol Vis Sci [ARVO Suppl] 20:23
Herschier J (1976) Increased intraocular pressure induced by repository corticosteroids. Am J Ophthalmol 82:90–93
Higgins SJ, Baxter JD, Rousseau GG (1979) Nuclear binding of glucocorticoid receptors. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 135
Hills AG, Forsham PH, Finch CA (1948) Changes in circulating leukocytes induced by the administration of pituitary adrenocorticotrophic hormone (ACTH) in man. Blood 3:755–768
Hogan MJ, Thygesen P, Kimura SJ (1955) Uses and abuses of adrenal steroids and corticotropin. Arch Ophthalmol 53:165–176
Hull DS, Hine JE, Edelhauser HF, Hyndiuk RA (1974) Permeability of the isolated rabbit cornea to corticosteroids. Invest Ophthalmol 13:457–459
Hyndiuk RA (1969) Radioactive depot-corticosteroid penetration into monkey ocular tissue. II. Subconjunctival administration. Arch Ophthalmol 82:259–262
Hyndiuk RA, Reagan MG (1968) Radioactive depot-cortisol penetration into monkey ocular tissue. I. Retrobulbar and systemic administration. Arch Ophthalmol 80:499–503
Ilfeld DN, Krakauer RS, Blaese RM (1977) Suppression of the autologous mixed lymphocyte reaction by physiologic concentrations of hydrocortisone. J Immunol 119:428–434
Ingle DJ (1938) Atrophy of the thymus in normal and hypophysectomized rats following administration of cortin. Proc Soc Exp Biol Med 38:443–444
Ingle DJ (1950) The biologic properties of cortisone: a review. J Clin Endocrinol Metab 10:1312–1354
Ingle DJ (1952) The role of the adrenal cortex in homeostasis. J Endocrinol 8:23–37
Jampol LM, West C, Goldberg MF (1978) Therapy of scleritis with cytotoxic agents. Am J Ophthalmol 86:266–271
Johnson LK, Baxter JD, Rousseau GG (1979) Mechanisms of glucocorticoid receptor function. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 305
Johnson-Wint B (1980) Regulation of stromal cell collagenase production in adult rabbit cornea: in vitro stimulation and inhibition by epithelial cell products. Proc Natl Acad Sci USA 77:5331–5335
Jones DB (1974) Herpes zoster ophthalmicus. In: Golden B (ed) Ocular inflammatory disease. Thomas, Springfield, p 198
Jones IS, Meyer K (1950) Inhibition of vascularization of the rabbit cornea by local application of cortisone. Proc Soc Expt Biol Med 74:102–104
Kalina RE (1969) Increased intraocular pressure following subconjunctival corticosteroid administration. Arch Ophthalmol 18:788–790
Kantrowitz F, Robinson DR, McGuire MB, Levine L (1975) Corticosteroids inhibit prostaglandin production by rheumatoid synovia. Nature 258:737–739
Kaplan HJ, Diamond JG, Brown SA (1979) Vitrectomy in experimental uveitis II. Method in eyes with protein-induced uveitis. Arch Ophthalmol 97:336–339
Kaufman HE (1966) Use of corticosteroids in corneal disease and external diseases of the eye. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 827
Kaufman HE (1968) Topical corticosteroids: dose response relationships. In: Leopold IH (ed) Symposium on ocular therapy. Mosby, St. Louis, p 106
Kaufman HE (1974) Summary. In: Golden B (ed) Ocular inflammatory disease. Thomas, Springfield, p 321
Kaufman HE (1975) Practical considerations in the selection of anti-inflammatory agents. Trans Am Ophthalmol Otolaryn 79:OP89–OP94
Kayes J, Becker B (1969) The human trabecular meshwork in corticosteroid induced glaucoma. Trans Am Ophthalmol Soc 67:339–354
Kazuo S, Tsurufuji S (1981) Mechanism of anti-inflammatory action of glucocorticoids: re-evaluation of vascular constriction hypothesis. Br J Pharmacol 73:605–608
Keller N, Longwell AM, Birss SA (1976) Intermittent vs continuous steroid administration. Arch Ophthalmol 94:644–652
Kendall E (1971) Cortisone. Scribner, New York
Kimura SJ (1977) The use of corticosteroids and immunosuppressive drugs in uveitis. In: Brockhurst RJ, Boruchoff SA, Hutchinson B, Lessell S (eds) Controversies in ophthalmology. Saunders, Philadelphia, p 762
Kimura R, Maekawa N (1976) Effect of orally administered hydrocortisone on the ocular tension in primary open angle glaucoma subjects. Acta Ophthalmol 54:430–436
King JH, Weimer JR (1955) Prednisone (Meticorten) and prednisolone (Meticortelone) in opthalmology: experimental and clinical studies. Arch Ophthalmol 54:46–54
Kitazawa Y (1976) Increased intraocular pressure induced by corticosteroids. Am J Ophthalmol 82:492–495
Kitazawa Y, Horie T (1981) The prognosis of corticosteroid-responsive individuals. Arch Ophthalmol 99:819–823
Knepper PA, Breen M, Weinstein HG, Black LT 1978) Intraocular pressure and glycosaminoglycan distribution in the rabbit eye: effect of age and dexamethasone. Exp Eye Res 27:567–575
Kolker AE, Hetherington J (1976) Primary open-angle glaucoma. In: Kolker AE, Hetherington J (eds) Becker-Shaffer’s diagnosis and therapy of the glaucomas. Mosby, St. Louis, p 219
Kozower M, Veatch L, Kaplan MM (1974) Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab 38:407–412
Kroman HS, Leopold IH (1961) Studies upon methyl- and fluro-substituted prednisolones in the aqueous humor of the rabbit. Am J Ophthalmol 52:77–81
Krupin T, Waltman SR, Becker B (1974) Ocular penetration in rabbits of topically applied dexamethasone. Arch Ophthalmol 92:312–314
Kuck JFR (1977) Drugs influencing the lens. In: Dikstein S (ed) Drugs and ocular tissues. Karger, New York, p 433
Kupferman A, Leibowitz HM (1975) Therapeutic effectiveness of fluorometholone in inflammatory keratitis. Arch Ophthalmol 93:1011–1014
Kupferman A, Leibowitz HM (1976) Biological equivalence of ophthalmic prednisolone acetate suspensions. Am J Ophthalmol 82:109–112
Lamberts DW (1980) Solid delivery devices. Int Ophthalmol Clin 20(3):63–77
Leibowitz HM, Kupferman A (1975) Penetration of fluorometholone into the cornea and aqueous humor. Arch Ophthalmol 93:425–427
Leibowitz HM, Kupferman A (1980 a) Antiinflammatory medications. Int Ophthalmol Clin 20:117–134
Leibowitz HM, Kupferman A (1980 b) Topically administered corticosteroids: effect on antibiotic-treated bacterial keratitis. Arch Ophthalmol 98:1287–1290
Leibowitz HM, Kupferman A, Steward RH, Kimbrough RL (1978) Evaluation of dexamethasone acetate as a topical ophthalmic formulation. Am J Ophthalmol 86:418–423
Leopold IH (1970) Summation. In: Kaufman EH (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, p 245
Leopold IH (1974) Consideration of antiinflammatory drugs in ophthalmology. In: Leopold IH, Burns RP (eds) Symposium on ocular therapy. Wiley, New York, p 41.
Leopold IH, Kroman HS, Green H (1955) Intraocular penetration of prednisone and prednisolone. Tr Am Ophthalmol Otolaryn 59:771–777
Lerman S, Davis P, Jackson WB (1973) Prolonged release hydrocortisone therapy. Can J Ophthalmol 8:114–118
Levine ND, Aronson SB (1970) Orbital infusion of steroids in the rabbit. Arch Ophthalmol 83:599–607
Levine SB, Leopold IH (1973) Advances in ocular corticosteroid therapy. Med Clin North Am 57:62–77
Lewis GP, Piper PJ (1975) Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature 254:308–311
Linner E (1959) Adrenocorticosteroids and aqueous humor dynamics. Doc Ophthalmol 13:210–222
Lippman ME (1979) Glucocorticoid receptors and effects in human lymphoid and leukemic cells. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 377
Livanou T, Ferriman D, James VHT (1967) Recovery of the hypothalamo-pituitary-adrenal function after corticoid steroid therapy. Lancet II:856–859
Loredo A, Rodriguez R, Murillo L (1972) Letter to the editor. N Eng J Med 286:160
Lorenzetti DWC (1970) Therapeutic and toxic dose-response effects of corticosteroids. In: Kaufman HE (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, p 205
Lubow M, Adams L (1972) The changing management of acute optic neuritis. In: Smith JL (ed) Neuroophthalmology. Mosby, St. Louis
McDonald PR, Leopold IH, Vogel AW, Mulberger RD (1953) Hydrocortisone (compound F) in ophthalmology. Arch Ophthalmol 49:400–412
MacGregor RR (1976) The effect of anti-inflammatory agents and inflammation on granulocyte adherence. Evidence for regulation by plasma factors. Am J Med 61:597–607
Machemer R, Sugita G, Tano Y (1979) Treatment of intraocular proliferation with intraviteal steroids. Trans Am Ophthalmol Soc 77:172–179
Maibach HI, Stoughton RB (1975) Topical corticosteroids. In: Azarnoff DL (ed) Steroid therapy. Saunders, Philadelphia, p 174
Marchalonis JJ (1980) Cell interactions in immune responses. In: Fudenberg HH, Stites DP, Caldwell JL, Wells JV (eds) Basic and clinical immunology. Lange, Los Altos, p 115
Marsh RJ (1980) Herpes zoster. In: Fraunfelder FT, Roy FH (eds) Current ocular therapy. Saunders, Philadelphia, p 62
Martial JA, Seeburg PH, Matulich DT, Goodman HM, Baxter JD (1979) Regulation of growth hormone messenger RNA. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 279
McCarty G, Schwartz B (1980) Receptor-assessed plasma glucocorticoid activity in glaucoma. Invest Ophthalmol Vis Sci [ARVO Suppl] 19:125
McCarty G, Schwartz B, Miller K (1981) Absence of lymphocyte glucocorticoid hypersensitivity in primary open angle glaucoma. Arch Ophthalmol 99:1258–1260
McCuen II BW, Bessler M, Tano Y, Chandler D, Machemer R (1981) The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 92:785–788
McDonald PR, Leopold IH, Vogel AW, Mulberger RD (1953) Hydrocortisone (compound F) in ophthalmology. Arch Ophthalmol 49:400–412
McLean JM (1950) In discussion of Woods AC (77). Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Trans Am Ophthalmol Soc 48:259
McLeod KM, Baxter JD (1980) Molecular basis for hormone action. In: Bandy PK, Rosenberg LE (eds) Duncan’s diseases of metabolism. Saunders, Philadelphia, p 104
Meikle AW, Tyler FH (1977) Potency and duration of action of glucocorticoids. Am J Med 63:200–207
Meikle AW, Weed JA, Tyler FH (1975) Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunoassays. J Clin Endocrinol Metab 4:717–721
Meikle AW, Clark DH, Tyler FH (1976) Cushing syndrome from low doses of dexamethasone. JAMA 235:1592–1593
Menkin V (1940) Effect of adrenal cortex extract on capillary permeability. Am J Physiol 129:691–697
Metcalf JF, Kaufman HE (1976) Herpetic stromal keratitis — evidence for cell-mediated immunopathogenesis. Am J Ophthalmol 82:827–834
Meyers FH, Jawetz E, Goldfien A (1980) The adrenocorticol steroids. In: Meyers FH, Jawetz E, Goldfien A (eds) Review of medical pharmacology. Lange. Los Altos, p 353
Meyers RL, Pettit TH (1974) Chemotaxis of polymorphonuclear leukocytes in corneal inflammation: tissue injury in herpes simplex virus infection. Invest Ophthalmol 13:187–197
Mindel JS, Tavitan HO, Smith H, Walker EC (1980) Comparative ocular pressure elevation by medrysone, fluorometholone and dexamethasone phosphate. Arch Ophthalmol 97:1577–1578
Moller G (1980) Role of macrophages in the immune response. Immunol Rev 40:1
Monder C, Bradlow L (1980) Cortoic acids: explorations at the frontier of corticosteroid metabolism. Recent Prog Horm Res 36:345–400
Moscona AA, Piddington R (1966) Stimulation by hydrocortisone of premature changes in the developmental pattern of glutamine synthetase in embryonic retina. Biochem Biophys Acta 121:409–411
Munck A, Young DA (1975) Corticosteroids and lymphoid tissue. In: Geiger SR (ed) Handbook of physiology, vol VI. American Physiological Society, Washington DC, p 231
Munck A, Crabtree GR, Smith KA (1979) Glucocorticoid receptors and actions in rat thymocytes and immunologically stimulated human peripheral lymphocytes. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 341
Nagataki S, Mishima S (1980) Pharmacokinetics of instilled drugs in the human eye. Int Clin Ophthalmol 20:33–49
Nagy RM, McFall RC, Sery TW (1980) Cell-mediated immunity in herpes corneal stromal disease. Invest Ophthalmol Vis Sci 19:271–277
Nelson EL (1970) Ophthalmic steroids. In: Kaufman HE (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, p 217
Nesburn AB (1981) Immunological aspects of ocular herpes simplex disease. In: Suran A, Gery I, Nussenblatt RB (eds) Immunology of the eye: workshop III. Information Retrieval, Washington DC, p 21
Neufeld AH (1978) Influences of cyclic nucleotides on outflow facility in the vervet monkey. Exp Eye Res 27:387–397
Neufeld AH, Dueker DK, Vegge T, Sears ML (1975) Adenosine 3′,5′-monophosphate increases the outflow of aqueous humor from the rabbit eye. Invest Ophthalmol 14:40–42
Neuner HP, Dardenne V (1968) Augenveränderungen bei Cushing Syndrom. Klin Monatsbl Augenheilkd 152:570–574
Newsome DA, Gross J (1977) Prevention by medroxyprogesterone of perforation in alkaliburned rabbit cornea: inhibition of collagenolytic activity. Invest Ophthalmol 16:21–31
Newsome DA, Gross J (1979) Regulation of corneal collagenase production: stimulation by serially passaged stromal cells by blood monocular cells. Cell 16:895–900
Newsome DA, Wong VG, Cameron TP, Anderson RA (1971) “Steroid-induced” mydriasis and ptosis. Invest Ophthalmol 10:424–429
Nichols T, Nugent CA, Tyler FH (1965) Diurnal variation in suppression of adrenal function by glucocorticoids. J Clin Endocrin Metab 25:343–349
Nielsen RH (1959) The use of dexamethasone in ophthalmologic steroid therapy. Arch Ophthalmol 62:438–444
Nozik RA (1972) Periocular injection of steroids. Trans Am Ophthalmol Otolaryngol 76:695–705
O’Connor GR (1975) Basic mechanisms responsible for the initiation and perpetuation of anterior segment inflammation. Trans Am Ophthalmol Otolaryngol 79:OP56–OP61
O’Connor GR (1980) Corticosteroids and immunosuppressives reviewed. In: Srinivasan (ed) Ocular therapeutics. Masson, New York, p 69
O’Connor GR (1981 a) The inflammatory response. In: Suran A, Gery I, Nussenblatt RB (eds) Immunology of the eye: workshop III. Information Retrieval, Washington DC, p 225
O’Connor GR (1981 b) Workshop on inflammation, infection, and allergy: general summary. In: Suran A, Gery I, Nussenblatt RB (eds) Immunology of the eye: workshop III. Information Retrieval, Washington DC, p 519
O’Farrell PH, Ivarie RD (1979) The glucocorticoid domain of response: measurement of pleiotropic cellular responses by two-dimensional gel electrophoresis. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 189
Oglesby RB, Black RL, von Sallmann T, Bunim JJ (1961) Cataracts in rheumatoid arthritis patients treated with corticosteroids. Arch Ophthalmol 66:519–523
Olson JA, Steffensen EH, Margulis RR, Smith RW, Whitney EL (1950) Effect of ACTH on certain inflammatory diseases of the eye. JAMA 142:1276–1278
Olson JA, Steffenson EH, Smith RW, Margulis RR, Whitney EL (1951) Use of adrenocorticotropic hormone and cortisone in ocular disease. Arch Ophthalmol 45:274–300
Ono S, Hirano H, Obara K (1971) Degradation of the side chain of Cortisol by lens homogenate. Tohoku J Exp Med 104:171–175
Ostler HB (1978) Glucocorticoid therapy in ocular herpes simplex. I. Limitations. Surv Ophthalmol 23:35–43
Ostler HB, Lanier JD (1974) Phlyctenular keratoconjunctivitis with special reference to the staphylococcal type. Trans Pac Coast Otoophthalmol Soc Ann Mtg 55:237–252
Palmberg PF, Mandell L, Wilensky JT, Podos SM, Becker B (1975) The reproducibility of the intraocular pressure response to dexamethasone. Am J Ophthalmol 80:844–856
Parrillo JE, Fauci AS (1979) Mechanisms of glucocorticoid action on immune processes. Ann Rev Pharmacol Toxicol 19:179–201
Pavan-Langston D (1976) New drug delivery systems. In: Leopold IH, Burns RP (eds) Symposium on ocular therapy. Wiley, New York, p 17
Pavan-Langston D, Abelson MB (1978) Glucocorticoid therapy in ocular herpes simplex. II. Advantages. Surv Ophthalmol 23:35–48
Perkin GD, Rose FC (1979) Treatment. In: Perkin GD, Rose FC (eds) Optic neuritis and its differential diagnosis. Oxford University Press, Oxford, p 172
Peterkofsky B, Tomkins GM (1967) Effect of inhibitors of nucleic acid synthesis on steroid-mediated induction of tyrosine aminotransferase in hepatoma cell cultures. J Mol Biol 30:49–61
Phillpotts JS (1969) Intra-ocular medication with special reference to depomedrone. Trans Ophthalmol Soc UK 138:729–735
Piperberg JB (1978) Binding of steroids to the cytoplasmic receptor of the embryonic chick retina: kinetics and structural considerations. Arch Biochem Biophys 191:367–374
Podos SM, Krupin T, Asseff C, Becker B (1971) Topically administered corticosteroid preparations. Arch Ophthalmol 86:251–254
Polansky JR, Gospodarowicz D, Weinreb RN, Alvarado JJ (1978) Human trabecular meshwork cell culture and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci [ARVO Suppl] 17:207
Polansky JR, Weinreb RN, Baxter JD, Alvarado JJ (1979) Human trabecular cells. I. Establishment in tissue culture. Invest Ophthalmol 18:1043–1049
Polansky JR, Weinreb RN, Alvarado JJ (1980) Studies on human trabecular cells propagated in vitro. Vision Res 21:155
Polansky JR, Palmberg PF, Nakanistu M, Coit D, Matulich DI, Lan NC, Hajek S, Becker B, Baxter JD (to be published) Cellular sensitivity to glucocorticoids in patients with primary open-angle glaucoma: steroid receptors and biological responsiveness of cultured skin fibroblasts. Invest Ophthalmol Vis Sci
Posthumus RG (1952) The use and the possibilities of progesterone in the treatment of glaucoma. Ophthalmologica 124:2
Raichaind M, Peyman G, Schwartz H, Roe C (1982) Anti-inflammatory action of dexamethasone in vitrectomy infusion fluid. Ophthalmic Surg 13:493–198
Rocklin RE (1980) Mediators of cellular immunity. In: Fudenberg HH, Stites DP, Caldwell JL, Wells JV (eds) Basic and clinical immunology. Lange, Los Altos, p 144
Rohen JW, Linner E, Witmer R (1973) Electron microscopic studies on the trabecular mesh-work in two cases of corticosteroid-glaucoma. Exp Eye Res 17:19–31
Rooklin AR, Lampert SI, Jaeger EA, McGeady SJ, Mansmann HC (1979) Posterior subcapsular cataracts in steroid-requiring asthmatic children. Allergy Clin Immunol 63:383–386
Rosenthal AR, Balow JE (1980) Mechanisms of glucocorticosteroid suppression of cell-mediated immunity. Immunol Rev 40:701
Rosenthal AR, Appelton B, Zimmerman R, Hopkins JL (1976) Intraocular copper foreign bodies: use of dexamethasone to suppress inflammation. Arch Ophthalmol 94:1571–1576
Rousseau GG (1974) Interaction of steroids with hepatoma cells: molecular mechanisms of glucocorticoid hormone action. J Steroid Biochem 6:75–89
Rousseau GG, Baxter JD (1979) Glucocorticoid receptors. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 49
Samuels H, Tompkins GM (1970) Relation of steroid structure to enzyme induction in hepatoma tisue culture cells. J Mol Biol 52:57–74
Sano T, Miyata Y (1971) Autopsy findings in a case of steroid glaucoma. Jpn J Clin Ophthalmol 25:153–160
Sarett LH (1946) Partial synthesis of 4-pregne-17 beta, 20 beta, 21-triol-3, 11-dione and 4-pregne-17 beta-21 diol-3,11-30-trione monoacetate. J Biol Chem 162:601–631
Schachtschabel B, Bigalke B, Rohen JW (1977) Production of glycosaminoglycans by cell cultures of the trabecular meshwork of the primate eye. Exp Eye Res 24:71–80
Schatz M, Patterson R, Zeit S, O’Rourke J, Melam H (1975) Corticosteroid therapy for the pregnant asthmatic patient. JAMA 233:804–807
Schayer RW (1963) Induced synthesis of histamine, microcirculatory regulation and the mechanism of action of the adrenal glucocorticoid hormones. Progr Allergy 7:187–212
Schlaegel TF (1970) Depot corticosteroids by the cul-de-sac route. In: Kaufman HE (ed) Symposium on ocular anti-inflammatory therapy. Thomas, Springfield, p 117
Schlaegel TF (1977) Complications of uveitis. Int Ophthalmic Clin 17:65–85
Schlaegel TF, O’Connor GR (1977) Nonspecific treatment. Int Ophthalmol Clin 17:43–62
Schlaegel TF, Wilson FM (1974) Accidental intraocular injection of depot corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 78:847
Schoenwald RD, Boltralik JJ (1979) A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations. Invest Ophthalmol 18:61–66
Schwartz B (1966 a) Physiological effects of corticosteroids on the eye. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 753
Schwartz B (1966 b) The response of ocular pressure to corticosteroids. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 929
Schwartz B (1966 c) Use of corticosteroids in the management of patients with glaucoma. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 1017
Schwartz B (1981 a) Ocular glucocorticoid therapy: a review of mechanisms of receptor and cellular action. In: Suran A, Gery I, Nussenblat RB (eds) Immunology of the eye: workshop III. Information Retrieval, Washington DC, p 425
Schwartz B (1981 b) Increased plasma Cortisol levels in ocular hypertension. Arch Ophthalmol 99:1791–1794
Schwartz JT, Rueling FH, Feinleib M, Garrison RJ, Collie DJ (1973 a) Twin study on ocular pressure after topical dexamethasone. 1. Frequency distribution of pressure response. Arch Ophthalmol 76:126–136
Schwartz JT, Rueling FH, Feinleib M, Garrison RJ, Collie DJ (1973 b) Twin study on ocular pressure following topically applied dexamethasone. 2. Inheritance of variation in pressure response. Arch Ophthalmol 90:281–286
Sears ML, Mead A (1983) A major pathway for the regulation of intraocular pressure. Internatl Ophthalmol 6:201–212
Selye H (1936) Thymus and adrenals in the response of the organism to injuries and intoxications. Br J Exp Pathol 17:234–248
Selye H (1946) The general adaptation syndrome and the diseases of adaptation. J Clin Endocrin 6:117–230
Shell JW (1982 a) Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 6:207–218
Shell JW (1982 b) Ocular drug delivery systems — a review. Cutan Ocular Toxicol 1:49–63
Shell JW, Baker RW (1974) Diffusional systems for controlled release of drugs to the eye. Ann Ophthalmol 6:1037–1045
Sherman MR (1979) Allosteric and competitive steroid-receptor interactions. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin heidelberg New York, p 123
Short C, Keates RH, Donovan EF, Wyman M, Murdick PW (1966) Ocular penetration studies. Arch Ophthalmol 75:689–692
Silverstein AM (1974) Mechanisms of ocular immunologic disease. In: Golden B (ed) Ocular inflammatory disease. Thomas, Springfield, p 3
Skalka HW, Prchal JT (1980) Effect of corticosteroids on cataract formation. Arch Ophthalmol 98:1773–1777
Smith JL, Stempfei RS, Campbell HS, Hudnell AB, Richman DW (1962) Diurnal variation of plasma 17-hydroxycorticoids and intraocular pressure in glaucoma. Am J Ophthalmol 54:411–418
Smith R, Nozik RA (1982) Uveitis: a clinical approach to diagnosis and management. Williams and Wilkins, Baltimore, p 1
Smolin G, Hall JM, Okumoto M, Ohno S (1977) High doses of subconjunctival corticosteroid and antibody-forming cells in the eye and draining lymph nodes. Arch Ophthalmol 95:1631–1633
Southren AL, Altman K, Vittek J, Boniuk V, Gordon GG (1976) Steroid metabolism in ocular tissues of the rabbit. Invest Ophthalmol 15:222–228
Southren AL, Gordon GG, Yeh HS, Dunn MW, Weinstein BI (1977) Receptors for glucocorticoids in the lens epithelium of the calf. Science 200:1177–1178
Southren AL, Gordon CG, Yeh HS, Dunn MW, Weinstein BI (1979) Nuclear translocation of the cytoplasmic glucocorticoid receptor in the iris-ciliary body of the rabbit. Invest Ophthalmol Vis Sci 18:517–521
Southren AL, Ochoa Dominguez M, Gordon GG, Dunn MW, Weinstein BI (1982 a) Nuclear translocation of the glucocorticoid receptor in the rabbit iris-ciliary body following topical administration of various anti-inflammatory steroids. Invest Ophthal Vis Sci [Suppl] 56:93
Sowell JG, Levene RZ, Bloom J, Bernstein M (1977) Primary open angle glaucome and sensitivity to corticosteroids in vitro. Am J Ophthalmol 84:715–720
Spaeth GL (1969) General medications, glaucoma and disturbances of intraocular pressure. Med Clin North Am 53(5):1109–1121
Spaeth GL (1980) The effect of autonomic agents on the pupil and the intraocular pressure of eyes treated with dexamethasone. Br J Ophthalmol 64:426–429
Spaeth GL, von Sallmann L (1966) Corticosteroids and cataracts. In: Schwartz B (ed) Corticosteroids and the eye. Little, Brown, Boston, p 915
Spaeth GL, Rodrigues MM, Weinreb S (1977) Steroid induced glaucoma. Trans Am Ophthalmol Soc 75:353–381
Steck WF, Lockwood DH (1979) Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 66:910–914
Steiger M, Reichstein Q (1937) Desoxy-corticosterone (21-oxy-progesterone) aus Delta 5-3-oxy-atiokohlensäure. Helv Chim Acta 20:1164–1179
Stern GA, Okumoto MA, Friedlaender M, Smolin G (1980) The effect of combined gentamicin-corticosteroid treatment on gentamicin-resistant Pseudomonas keratitis. Ann Ophthalmol 12:9
Stewart RH, Kimbrough RL (1979) Intraocular pressure response to topically administered fluorometholone. Arch Ophthalmol 97:2139–2140
Suddick RP (1966) Glucocorticoid-kinin antagonism in the rat. Am J Physiol 211:844–850
Sugar J, Burde RM, Sugar A, Waltman SR, Kripalani KJ, Weliky I, Becker B (1972) Tetrahydrotriamcinolone and triamcinolone I. Ocular penetration. Invest Ophthalmol 11:890–893
Swingle WW, Pfiffner JJ (1930) An aqueous extract of the suprarenal cortex which maintains the life of bilaterally adrenalectomized cats. Science 71:321–322
Swingle WW, Pfiffner JJ (1931) Studies on the adrenal cortex. I. The effect of lipid fraction upon the life span of adrenalectomized-cats. Am J Physiol 96:153–163
Tamada Y, Miyashita H, Ono S (1980) Studies on the phospholipid metabolism of rabbit lens with special reference to long-term topical administration of steroid. Jpn J Ophthalmol 24:289–296
Tano Y, Chandler D, Machemer R (1980 a) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816
Tano Y, Sugita G, Abrams G, Machemer R (1980 b) Inhibition of intraocular proliferations with intravitreal corticosteroids. Am J Ophthalmol 89:131–136
Tano Y, Chandler BS, Machemer R (1980 c) Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 90:810–816
Tano Y, Chandler DB, McCuen BW, Machemer R (1981) Glucocorticosteroid inhibition of intraocular proliferation after injury. Am J Ophthalmol 91:184–189
Tchernitchin A, Wend EJ, Hernandez M, Weinstein B, Dunn MW, Gordon G, Southren AL (1980) Glucocorticoid localization by radioautography in the rabbit eye following systemic administration of3 H-dexamethasone. Invest Ophthalmol Vis Sci 19:1231–1235
Thompson EB (1979 a) Glucocorticoid induction of tryosine aminotransferase in cultured cells. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 203
Thompson EB (1979 b) Glucocorticoids and lysosomes. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 575
Thygesen P (1977) The unfavorable role of corticosteroids in herpetic keratitis. In: Brockhurst RJ, Boruchoff SA, Hutchinson B, Lessell S (eds) Controversies in ophthalmology. Saunders, Philadelphia, p 450
Thygesen P, Hogan MJ, Kimura SJ (1960) The unfavorable effect of topical steroid therapy on herpetic keratitis. Trans Am Ophthalmol Soc 58:245–262
Ticho V, Vilahav M, Berkowitz S, Yoffe B (1979) Ocular changes in rabbits with corticosteroid-induced ocular hypertension. Br J Ophthalmol 63:646–650
Tsurufuji S, Sugio K, Takemasa F (1979) The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 280:408–410
Tsurufuji S, Sugio K, Takemasa F, Yoshizawa S (1980) Blockade by antiglucocorticoids, actionomycin D and cycloheximide of anti-inflammatory action of dexamethasone against bradykinin. J Pharmacol Exp Ther 212:225–231
Tyrrell JB, Baxter JD (1981) Glucocorticoid therapy. In: Felig P, Baxter JD, Broadus AE, Frohman LA (eds Endocrinology and metabolism. McGraw-Hill, New York, p 599
Valerio M, Carones AV, DePoli A (1962) Il quadro clinico del glaucoma da cortisonoterapia locale. Gior Ital Oftal 15:143–150
Vassalli J, Hamilton J, Reich E (1976) Macrophage plasminogen activator modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors and cyclic nucleotides. Cell 8:271–281
Vermeulen A (1959) The metabolism of 4–14 C prednisolone. J Endocrinol 18:278–291
Vincenti F, Amend W, Feduska NJ, Duca RM, Salvatierra Jr O (1980) Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. Am J Med 69:107–112
Vischer TL (1972) Effect of hydrocortisone on the reactivity of thymus and spleen cells of mice to in vitro stimulation. Immunology 233:777–784
Weinreb RN, Kimura SJ (1979) Uveitis associated with sarcoidosis and angiotensin converting enzyme. Trans Am Ophthalmol Soc 77:280–293
Weinreb RN, O’Donnell JT, Alvarado JJ, Baxter JD, Polansky JR (1978) Specific nuclear steroid binding in cultured human trabecular cells. Invest Ophthalmol Vis Sci [ARVO Suppl] 17:204
Weinreb RN, Polansky JR, Kramer SG, Baxter JD (1979) Acute intraocular pressure response to steroids in glaucoma. Invest Ophthalmol Vis Sci [ARVO Suppl] 18:41
Weinreb RN, Bloom E, Baxter JD, Alvarado J, Lan N, O’Donnell J, Polansky JR (1981) Detection of glucocorticoid receptors in cultured human trabecular cells. Invest Ophthalmol 21:403–407
Weinreb RN, Mitchell M, Polansky JP (in press) Prostaglandin synthesis by human trabecular cells: inhibitory effect of dexamethasone. Invest Ophthalmol Vis Sci [ARVO Suppl]
Weinstein BI, Altman K, Gordon G, Dunn M, Southren AL (1977) Specific glucocorticoid receptor in the iris-ciliary body of the rabbit. Invest Ophthalmol Vis Sci 16:973–976
Weissmann G, Thomas L (1963) Studies on lysosomes. II. The effect of cortisone on the release of acid hydrolases from a large granule fraction of rabbit liver induced by an exccess of vitamin A. J Clin Invest 42:661–669
Weitzman ED, Henkind P, Leitman M, Hellman L (1975) Correlative 24-hour relationships between intraocular pressure and plasma Cortisol in normal subjects and patients with glaucoma. Br J Ophthalmol 59:566–572
Wenk EJ, Rosario-Hernandez M, Weinstein BI, Gordon GG, Dunn MW, Southren AL (1982) Glucocorticoid receptor binding in bovine lens. Invest Ophthalmol Vis Sci 22:599–605
Werb Z (1978) Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. J Exp Med 147:1695–1712
Werb Z, Foley R, Munck A (1978) Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinase in a macrophage line. J Immunol 121:115–121
Whiteman DW, Rosen DA, Pinkerton RMH (1980) Retinal and choroidal microvascular embolism after intranasal corticosteroid injection. Am J Ophthalmol 89:851–853
Williams GH, Dluhy RG, Thorn GW (1980) Diseases of the adrenal cortex. In: Isselbacher KJ, Adams RD, Braunwald E, Petersdorf RG, Wilson JD (eds) Harrison’s principles of internal medicine, 9th edn, McGraw-Hill New York, p 1734
Wolff ME (1979) Structure-activitiy relationships in glucocorticoids. In: Baxter JD, Rousseau GG (eds) Glucocorticoid hormone action. Springer, Berlin Heidelberg New York, p 97
Woods AC (1950) Clinical and experimental observation on the use of ACTH and cortisone in ocular inflammatory disease. Am J Ophthalmol 333:1325–1349
Woods AC, Wood RM (1950) Action of ACTH and cortisone on experimental ocular inflammation. Bull Johns Hopkins Hosp 87:482–504
Woods AC, Wood RM (1952) Studies in experimental ocular tuberculosis, Arch Ophthalmol 47:477–512
Woods AC, Wood RM (1958) Studies in experimental ocular tuberculosis. Arch Ophthalmol 59:559–578
Wray S (1977) ACTH and oral corticosteroids in the treatment of acute optic neuritis. In: Brockhurst RT, Boruchoff SA, Hutchinson B, Lessell S (ed) Controversies in ophthalmology. Saunders, Philadelphia, pp 830–838
Yablonski ME, Burde RM, Kolker AE, Becker B (1978) Cataracts induced by topical dexamethasone in diabetics. Arch Ophthalmol 96:474–476
Yamauchi H, Kito H, Uda K (1975) Studies on intraocular penetration and metabolism of fluorometholone in rabbits: a comparison between dexamethasone and prednisolone acetate. Jpn J Ophthalmol 19:339–347
Zaidman GW, Brown SI (1981) Phlyctenular keratoconjunctivitis. Am J Ophthalmol 92:178–182
Zimmerman TJ, Dawson WW, Fitzgerald CR (1973) Part I: Electroretinographic changes in normal eyes during administration of prednisone. Ann Ophthalmol 5:757–765
Zinn K (1981) Iatrogenic intraocular injection of depot corticosteroid and its surgical removal using the pars plana approach. Ophthalmology 88:13–17
Zumbrun FA, Weinreb RN, Alvarado JA, Polansky JR (1981) Endogenous hyaluronidase and degradation of hyaluronic acid by human trabecular cells. Invest Ophthalmol Vis Sci [ARVO Suppl] 20:23
Zweifach BW, Shorr E, Black MM (1953) The influence of the adrenal cortex on behaviour of terminal vascular bed. Ann NY Acad Sci 56:626–633
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Polansky, J.R., Weinreb, R.N. (1984). Anti-Inflammatory Agents. In: Sears, M.L. (eds) Pharmacology of the Eye. Handbook of Experimental Pharmacology, vol 69. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69222-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-69222-2_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69224-6
Online ISBN: 978-3-642-69222-2
eBook Packages: Springer Book Archive